(3S)-1-(4-fluorophenyl)-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid

• 分子结构分类: 有机化合物 - 生物碱及其衍生物 - 哈马拉生物碱
• 英文名称: (3S)-1-(4-fluorophenyl)-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid
• 英文别名: (3S)-1-(4-fluorophenyl)-2,3,4,9-tetrahydro-1H-beta-carbolin-2-ium-3-carboxylate；(3S)-1-(4-fluorophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-2-ium-3-carboxylate
• 化学式: C₁₈H₁₅FN₂O₂
• 分子量: 310.328
• InChiKey: KUJITIQQDMJFKR-VYRBHSGPSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  23
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  65.1
• 氢给体数：
  3
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (3S)-1-(4-fluorophenyl)-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid 在 氯化亚砜 、 sulfur 作用下， 以 5,5-dimethyl-1,3-cyclohexadiene 为溶剂， 生成 methyl 1-(4-fluorophenyl)-9H-pyrido[3,4-b]indole-3-carboxylate
  参考文献：
  名称：

  Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer’s disease

  摘要：

  A series of tacrine-(beta-carboline) hybrids (11a-q) were designed, synthesized and evaluated as multifunctional cholinesterase inhibitors against Alzheimer's disease (AD). In vitro studies showed that most of them exhibited significant potency to inhibit acetylcholinesterase (eeAChE and hAChE), butyrylcholinesterase (BuChE) and self-induced beta-amyloid (A beta) aggregation, Cu2+-induced A beta (1-42) aggregation, and to chelate metal ions. Especially, 11l presented the greatest ability to inhibit cholinesterase (IC50, 21.6 nM for eeAChE, 63.2 nM for hAChE and 39.8 nM for BuChE), good inhibition of A beta aggregation (65.8% at 20 mu M) and good antioxidant activity (1.57 trolox equivalents). Kinetic and molecular modeling studies indicated that 11l was a mixed-type inhibitor, binding simultaneously to the catalytic anionic site (CAS) and the peripheral anionic site (PAS) of AChE. In addition, 11l could chelate metal ions, reduce PC12 cells death induced by oxidative stress and penetrate the blood-brain barrier (BBB). These results suggested that 11l might be an excellent multifunctional agent for AD treatment. (C) 2014 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2014.08.035
• 作为产物：
  描述：

  对氟苯甲醛 、 L-色氨酸 在 溶剂黄146 作用下， 反应 2.0h， 以75%的产率得到(3S)-1-(4-fluorophenyl)-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid
  参考文献：
  名称：

  Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer’s disease

  摘要：

  A series of tacrine-(beta-carboline) hybrids (11a-q) were designed, synthesized and evaluated as multifunctional cholinesterase inhibitors against Alzheimer's disease (AD). In vitro studies showed that most of them exhibited significant potency to inhibit acetylcholinesterase (eeAChE and hAChE), butyrylcholinesterase (BuChE) and self-induced beta-amyloid (A beta) aggregation, Cu2+-induced A beta (1-42) aggregation, and to chelate metal ions. Especially, 11l presented the greatest ability to inhibit cholinesterase (IC50, 21.6 nM for eeAChE, 63.2 nM for hAChE and 39.8 nM for BuChE), good inhibition of A beta aggregation (65.8% at 20 mu M) and good antioxidant activity (1.57 trolox equivalents). Kinetic and molecular modeling studies indicated that 11l was a mixed-type inhibitor, binding simultaneously to the catalytic anionic site (CAS) and the peripheral anionic site (PAS) of AChE. In addition, 11l could chelate metal ions, reduce PC12 cells death induced by oxidative stress and penetrate the blood-brain barrier (BBB). These results suggested that 11l might be an excellent multifunctional agent for AD treatment. (C) 2014 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2014.08.035

文献信息

• PhI(OAc)₂-mediated one-pot oxidative decarboxylation and aromatization of tetrahydro-β-carbolines: synthesis of norharmane, harmane, eudistomin U and eudistomin I
  作者：Ahmed Kamal、Yellaiah Tangella、Kesari Lakshmi Manasa、Manda Sathish、Vunnam Srinivasulu、Jadala Chetna、Abdullah Alarifi

  DOI：10.1039/c5ob00871a

  日期：——

  A new strategy for synthesis of β-carbolines via one-pot oxidative decarboxylation at room temperature is developed for the first time.

  首次开发了一种在室温下通过一锅法氧化脱羧合成β-咔啉的新策略。

• An efficient one-pot decarboxylative aromatization of tetrahydro-β-carbolines by using N-chlorosuccinimide: total synthesis of norharmane, harmane and eudistomins
  作者：Ahmed Kamal、Manda Sathish、A. V. G. Prasanthi、Jadala Chetna、Yellaiah Tangella、Vunnam Srinivasulu、Nagula Shankaraiah、Abdullah Alarifi

  DOI：10.1039/c5ra16221a

  日期：——

  A mild one-pot synthesis of β-carbolines from their tetrahydro-β-carboline acids has been developed via decorboxylative aromatization using N-chlorosuccinimide (NCS).

  一种从四氢β-咔啉酸合成β-咔啉的温和一锅法已经开发出来，通过使用N-氯代琥珀酰亚胺（NCS）进行脱羧芳构化。
• Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer’s disease
  作者：Jin-Shuai Lan、Sai-Sai Xie、Su-Yi Li、Long-Fei Pan、Xiao-Bing Wang、Ling-Yi Kong

  DOI：10.1016/j.bmc.2014.08.035

  日期：2014.11

  A series of tacrine-(beta-carboline) hybrids (11a-q) were designed, synthesized and evaluated as multifunctional cholinesterase inhibitors against Alzheimer's disease (AD). In vitro studies showed that most of them exhibited significant potency to inhibit acetylcholinesterase (eeAChE and hAChE), butyrylcholinesterase (BuChE) and self-induced beta-amyloid (A beta) aggregation, Cu2+-induced A beta (1-42) aggregation, and to chelate metal ions. Especially, 11l presented the greatest ability to inhibit cholinesterase (IC50, 21.6 nM for eeAChE, 63.2 nM for hAChE and 39.8 nM for BuChE), good inhibition of A beta aggregation (65.8% at 20 mu M) and good antioxidant activity (1.57 trolox equivalents). Kinetic and molecular modeling studies indicated that 11l was a mixed-type inhibitor, binding simultaneously to the catalytic anionic site (CAS) and the peripheral anionic site (PAS) of AChE. In addition, 11l could chelate metal ions, reduce PC12 cells death induced by oxidative stress and penetrate the blood-brain barrier (BBB). These results suggested that 11l might be an excellent multifunctional agent for AD treatment. (C) 2014 Elsevier Ltd. All rights reserved.